#18 - Daiichi-Sankyo

3-5-1 Nihombashi-honcho
Chuo-ku, Tokyo, 103-8426 (Japan)
Tel: (81) 3 6255 1111
Fax: (81) 3 5255 7035
www.daiichisankyo.co.jp

Headcount	18,434
Year Established	2005
Pharma Revenues	$7,166	+3%
Total Revenues	$7,957	-3%
Net Income	$672	-13%
R&D Budget	$1,460	+4%

Top Selling Drugs
Drug	Indication	Sales	(+/-%)
olmesartan	hypertension	$1,372	+68%
levofloxacin	anti-infection	$891	-1%
pravastatin	cholesterol	$800	-37%

Account for 43% of total pharma sales, same as in 2005.

For the full profile, including pipeline and patent information, download the PDF.